Skip to content

Martine A Rothblatt, Chairperson & CEO at UNITED THERAPEUTICS, sold UTHR on Sep 14, 2026

Data as of Oct 16

▼ SELL$793K1,580 shares at $502.15Martine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp
Watch UTHR
Traded
Sep 14, 2026
Disclosed
Sep 15, 2026
Filed
1 day after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Martine A Rothblatt, Chairperson & CEO at UNITED THERAPEUTICS, sold UTHR on Sep 14, 2026TRADEDDISCLOSED
UTHRSimilar stocks (XLV — its sector index fund), rebased to UTHR's price on the disclosure day
UTHR since disclosure
+6.5%
after the sale
Similar stocks (XLV) since disclosure
+5.4%
XLV — its sector index fund

Change in closing price from Sep 15, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$1.4Mdisclosed Sep 15 · filed 1 day after the trade
  2. ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$1.2Mdisclosed Sep 15 · filed 1 day after the trade
  3. ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$1.2Mdisclosed Sep 15 · filed 1 day after the trade
  4. ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$223Kdisclosed Sep 15 · filed 1 day after the trade

See every trade on UTHR →